Endogenous Erythropoietin and Outcome in Heart Failure
- 19 January 2010
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 121 (2) , 245-251
Abstract
Background— Endogenous erythropoietin is increased in patients with heart failure (HF). Previous small-scale data suggest that these erythropoietin levels are related to prognosis. This study aims to analyze the clinical and prognostic value of erythropoietin levels in relation to hemoglobin in a large cohort of HF patients. Methods and Results— In patients hospitalized for HF, endogenous erythropoietin levels were measured at discharge and after 6 months. In anemic patients, the relation between erythropoietin and hemoglobin levels was determined by calculating the observed/predicted ratio of erythropoietin levels. We studied data from 605 patients with HF. Mean age was 71±11 years; 62% were male; and mean left ventricular ejection fraction was 0.33±0.14. Median erythropoietin levels were 9.6 U/L at baseline and 10.5 U/L at 6 months. Higher erythropoietin levels at baseline were independently related to an increased mortality at 18 months (hazard ratio, 2.06; 95% confidence interval, 1.40 to 3.04; P P =0.044). The observed/predicted ratio was determined in a subset of anemic patients, 79% of whom had erythropoietin levels lower than expected and 9% had levels higher than expected on the basis of their hemoglobin. Multivariate Cox regression analysis revealed that a higher observed/predicted ratio was related to an increased mortality risk (hazard ratio, 3.52; 95% confidence interval, 1.53 to 8.12; P =0.003). Conclusions— Erythropoietin levels predict mortality in HF patients, and persistently elevated levels have an independent prognostic value. In anemic HF patients, the majority had a low observed/predicted ratio. However, a higher observed/predicted ratio may be related to an independent increased mortality risk.Keywords
This publication has 25 references indexed in Scilit:
- Erythropoietin levels in heart failure after an acute myocardial infarction: Determinants, prognostic value, and the effects of captopril versus losartanAmerican Heart Journal, 2009
- Effect of Moderate or Intensive Disease Management Program on Outcome in Patients With Heart FailureCoordinating Study Evaluating Outcomes of Advising and Counseling in Heart Failure (COACH)Archives of internal medicine (1960), 2008
- Adequacy of endogenous erythropoietin levels and mortality in anaemic heart failure patientsEuropean Heart Journal, 2008
- Erythropoietin in Chronic Heart FailureCongestive Heart Failure, 2007
- Drawbacks and Prognostic Value of Formulas Estimating Renal Function in Patients With Chronic Heart Failure and Systolic DysfunctionCirculation, 2006
- Circulating Erythropoietin Levels and Prognosis in Patients With Congestive Heart FailureArchives of internal medicine (1960), 2005
- Anemia of Chronic DiseaseNew England Journal of Medicine, 2005
- Prognostic value of plasma erythropoietin on mortality in patients with chronic heart failureJACC, 2004
- Design and Methodology of the COACH Study: A Multicenter Randomised C oordinating Study Evaluating O utcomes of A dvising and C ounselling in H eart FailureEuropean Journal of Heart Failure, 2004
- New automated chemiluminescent assay for erythropoietinJournal of Clinical Laboratory Analysis, 2000